Paper36979788
The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis.
David A and 4 others. Biomedicines, 2023. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis. Papers, record 36979788. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979788
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P41 GM103311 | NIGMS NIH HHS | United States | P41GM103311 | PubMed |
Source NIH RePORTER
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27211612 | A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA. | Mol Genet Metab | 2016 | https://conductscience.org/library/papers/27211612 | PubMed |
| 2 | 35868042 | Cathepsin S (CTSS) activity in health and disease - A treasure trove of untapped clinical potential. | Mol Aspects Med | 2022 | https://conductscience.org/library/papers/35868042 | PubMed |
| 3 | 29340594 | Keratan sulfate, a complex glycosaminoglycan with unique functional capability. | Glycobiology | 2018 | https://conductscience.org/library/papers/29340594 | PubMed |
| 4 | 33578874 | Epidemiology of Mucopolysaccharidoses Update. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/33578874 | PubMed |
| 5 | 23856419 | Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs. | Mol Genet Metab | 2013 | https://conductscience.org/library/papers/23856419 | PubMed |
| 6 | 12475197 | Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. | Chem Rev | 2002 | https://conductscience.org/library/papers/12475197 | PubMed |
| 7 | 11016923 | Cathepsin B activity regulation. Heparin-like glycosaminogylcans protect human cathepsin B from alkaline pH-induced inactivation. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11016923 | PubMed |
| 8 | 27053151 | Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus. | Mol Genet Metab | 2016 | https://conductscience.org/library/papers/27053151 | PubMed |
| 9 | 27234702 | Platelet lysate and chondroitin sulfate loaded contact lenses to heal corneal lesions. | Int J Pharm | 2016 | https://conductscience.org/library/papers/27234702 | PubMed |
| 10 | 31465828 | Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses. | Biochim Biophys Acta Mol Basis Dis | 2019 | https://conductscience.org/library/papers/31465828 | PubMed |
| 11 | 23860310 | Newborn screening and diagnosis of mucopolysaccharidoses. | Mol Genet Metab | 2013 | https://conductscience.org/library/papers/23860310 | PubMed |
| 12 | 35305807 | Cathepsin V: Molecular characteristics and significance in health and disease. | Mol Aspects Med | 2022 | https://conductscience.org/library/papers/35305807 | PubMed |
| 13 | 23968158 | Binding of chondroitin 4-sulfate to cathepsin S regulates its enzymatic activity. | Biochemistry | 2013 | https://conductscience.org/library/papers/23968158 | PubMed |
| 14 | 32224020 | Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses. | Mol Genet Metab | 2020 | https://conductscience.org/library/papers/32224020 | PubMed |
| 15 | 22024571 | Cysteine cathepsins: from structure, function and regulation to new frontiers. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22024571 | PubMed |
| 16 | 25103575 | Early treatment is associated with improved cognition in Hurler syndrome. | Ann Neurol | 2014 | https://conductscience.org/library/papers/25103575 | PubMed |
| 17 | 22403656 | Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology. | PLoS One | 2012 | https://conductscience.org/library/papers/22403656 | PubMed |
| 18 | 25872877 | Cathepsin S: therapeutic, diagnostic, and prognostic potential. | Biol Chem | 2015 | https://conductscience.org/library/papers/25872877 | PubMed |
| 19 | 35294848 | Spatiotemporal diversity and regulation of glycosaminoglycans in cell homeostasis and human disease. | Am J Physiol Cell Physiol | 2022 | https://conductscience.org/library/papers/35294848 | PubMed |
| 20 | 30710128 | Adeno-associated virus vector as a platform for gene therapy delivery. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30710128 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909579 | Thyroid involvement in lysosomal storage diseases: current evidence and clinical perspectives. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/42909579 | PubMed |
| 42898666 | Cathepsin S: a double-edged protease in barrier damage, neuroimmune inflammation, and tissue repair, with implications for dermatology. | Front Immunol | 2026 | https://conductscience.org/library/papers/42898666 | PubMed |
| 42843973 | Autolysosomal enhancer GHF201 attenuates pathophysiology in a mucopolysaccharidosis type I mouse model. | Life Sci Alliance | 2026 | https://conductscience.org/library/papers/42843973 | PubMed |
| 41503268 | Machine learning models for prediction of (Pro)cathepsin-glycosaminoglycan binding free energies based on molecular structure. | Comput Struct Biotechnol J | 2026 | https://conductscience.org/library/papers/41503268 | PubMed |
| 40748756 | Aggrecan protects against plaque accumulation and is essential for proper microglial responses to plaques. | Cell Rep | 2025 | https://conductscience.org/library/papers/40748756 | PubMed |
| 40104299 | Association of certain biochemical parameters related to bone cycle with genotype in MPS IIIB patients. | Turk J Med Sci | 2025 | https://conductscience.org/library/papers/40104299 | PubMed |
| 38396918 | An Unusual Two-Domain Thyropin from Tick Saliva: NMR Solution Structure and Highly Selective Inhibition of Cysteine Cathepsins Modulated by Glycosaminoglycans. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396918 | PubMed |
| 38256186 | Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38256186 | PubMed |
| 37195412 | Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach. | Metab Brain Dis | 2023 | https://conductscience.org/library/papers/37195412 | PubMed |
Genes52
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979788
GET https://conductscience.org/api/papers/v1/36979788/references?page=2